1_cancer (1)
π Society
Why inequality is passed from one generation to the next

Inequalities in the face of cancer : who are the most vulnerable ?

with Gwenn Menvielle, Research Director in Post-Cancer at Inserm and Aurore Loretti, Lecturer at ETHICS Laboratory's Medical Ethics Centre at Université Catholique de Lille
On December 10th, 2024 |
5 min reading time
Gwenn Menvielle
Gwenn Menvielle
Research Director in Post-Cancer at Inserm
Aurore Loretti
Aurore Loretti
Lecturer at ETHICS Laboratory's Medical Ethics Centre at Université Catholique de Lille
Key takeaways
  • Cancers more frequently affect the lower social classes, particularly the deadliest cancers, such as lung and upper aerodigestive tract cancers.
  • This disparity can be explained by the fact that disadvantaged groups are more exposed to risk factors such as smoking and exposure to carcinogenic substances before they become ill.
  • In France, health inequalities tend to worsen as the disease progresses, due to more frequent delays in diagnosis and lower levels of participation in screening campaigns among people from poorer backgrounds.
  • Studies show that these inequalities are more marked among men, particularly if they are isolated, than among women, although inequalities in mortality rates amongst women are increasing.
  • Inequalities also persist after the disease: for example, lung cancer, which is particularly impacted by social factors, leads to increased social inequalities and greater uncertainty when it comes to returning to work.

Throu­ghout the world, the poo­rer people are, the less heal­thy they are, and France is no excep­tion. Can­cer, the lea­ding cause of death in France, is a major contri­bu­tor to the country’s social inequa­li­ties in health, accoun­ting for 40% among men and 30% among women1. How does social sta­tus affect can­cer ? Various stu­dies show that it increases the risk of deve­lo­ping these diseases, makes the treat­ment pro­cess more dif­fi­cult and contri­butes to a decline in qua­li­ty of life after treatment.

Pre-disease : socially marked risk factors

It’s true that breast can­cer tends to affect more affluent people. But for the majo­ri­ty of other can­cers, the inci­dence is much higher among people from lower social classes. The dead­liest forms of can­cers (lung and upper aero­di­ges­tive tract) appear to be par­ti­cu­lar­ly asso­cia­ted with social deprivation.

How can this be explai­ned ? The ans­wer lies essen­tial­ly in the social deter­mi­nism of the main risk fac­tors. For example, while tobac­co consump­tion is una­ni­mous­ly reco­gni­sed as the major risk fac­tor for lung can­cer and one of the two main risk fac­tors, along­side alco­hol, for can­cers of the upper aero­di­ges­tive tract, 2.3 times as many people in the low socio-eco­no­mic classes smoke dai­ly as those in the high socio-eco­no­mic classes (the trend is rever­sed for alco­hol, howe­ver : consump­tion is 1.3 times higher in the high socio-eco­no­mic classes2).

But contra­ry to cer­tain pre­con­cei­ved ideas, this ris­ky consump­tion is not always the result of a total­ly free indi­vi­dual choice. In his book La ciga­rette du pauvre (The Poor Man’s Ciga­rette), Patrick Per­et­ti-Watel high­lights the ear­ly socia­li­sing role of ciga­rettes in disad­van­ta­ged groups, explai­ning that “pre­ca­rious­ness induces stress, which encou­rages smo­king(…). Pre­ca­rious­ness also shor­tens the time hori­zon, which impacts the abi­li­ty to put the harm­ful effects of smo­king in the long-term into pers­pec­tive”. Quit­ting smo­king, a major act of pre­ven­tion, is the­re­fore much more dif­fi­cult for people in pre­ca­rious situations.

Fur­ther­more, while smo­king is right­ly sin­gled out as a cause of inequa­li­ties, other risk fac­tors with a signi­fi­cant social impact, such as occu­pa­tio­nal expo­sure to car­ci­no­gens, should not be over­loo­ked. “Stu­dies indi­cate that the impact of these fac­tors has been much less stu­died, even though they seem to car­ry a great deal of weight. Heal­th­care pro­fes­sio­nals them­selves are less aware of them,” explains Aurore Loretti.

Des­pite the pro­gress made in recent decades, these expo­sure remains frequent in France. The latest sur­vey, Sur­veillance médi­cale des expo­si­tions des sala­riés aux risques pro­fes­sion­nels (Medi­cal Sur­veillance of Employee Expo­sure to Occu­pa­tio­nal Risks), car­ried out in 2017, sho­wed that 11% of employees had been expo­sed to at least one car­ci­no­gen in the last week wor­ked3. Half of these were blue-col­lar workers.

During the illness : an accumulation of inequalities

Inequa­li­ties are then com­poun­ded over the course of treat­ment. “Wha­te­ver the loca­tion of the can­cer, the lower your socio-eco­no­mic sta­tus, the lower your sur­vi­val rate” confirms Gwenn Menvielle.

Yet France has a num­ber of advan­tages. Its heal­th­care sys­tem is more effi­cient than many of its Euro­pean neigh­bours : while the num­ber of can­cer cases in the gene­ral popu­la­tion is higher (asso­cia­ted with higher ave­rage consump­tion of tobac­co and alco­hol, and lower vac­ci­na­tion rates against HPV), sur­vi­val rates are bet­ter. Per capi­ta spen­ding on can­cer care is among the highest in Europe, and the pro­por­tion of heal­th­care costs that patients pay is the lowest of all Euro­pean Union coun­tries4.

One might ima­gine that, with the finan­cial bar­rier at least par­tial­ly remo­ved, the influence of patients’ mate­rial cir­cum­stances would be less mar­ked than in neigh­bou­ring coun­tries. But this is not the case. Ano­ther obs­tacle stands in the way of the most disad­van­ta­ged people : the need to consult a doc­tor in the event of symp­toms or to under­go scree­ning. Signi­fi­cant delays in diag­no­sis are obser­ved in the least pri­vi­le­ged envi­ron­ments, and par­ti­ci­pa­tion rates in natio­nal scree­ning cam­pai­gns (for breast, cer­vi­cal and colon can­cer) are much lower among the most disad­van­ta­ged popu­la­tions. “Living in pre­ca­rious condi­tions can lead people to put pre­ven­tion on the back bur­ner, play down their symp­toms and put off see­king medi­cal advice by resor­ting to self-medication. 

But pre­ven­tion poli­cy also plays an impor­tant role. While breast can­cer receives a great deal of media cove­rage, we hear much less about colon can­cer, for example, des­pite the exis­tence of natio­nal scree­ning, or VADS can­cers. For the lat­ter, cam­pai­gns could be run to explain, for example, that you should consult a doc­tor if you have a lesion in your mouth that hasn’t hea­led in three weeks”, explains Aurore Loret­ti. And in fact, accor­ding to OECD 2023 figures, the bud­get spent by France on pre­ven­tion is well below the Euro­pean ave­rage5.

Post-diag­no­sis, other dif­fi­cul­ties com­pli­cate the conti­nua­tion of care. In 2020, the num­ber of doc­tors per capi­ta in France was well below the EU ave­rage (3.2 per 1,000 inha­bi­tants com­pa­red with 4 in Europe). While this shor­tage affects the popu­la­tion as a whole, it seems to have more adverse effects on disad­van­ta­ged people, with lon­ger delays in acces­sing care in par­ti­cu­lar, as sug­ges­ted by the 2014 VICAN2 sur­vey. Howe­ver, bet­ween 2017 and 2022, the num­ber of onco­lo­gists increa­sed by 30% and the num­ber of radio­the­ra­pists by 8%6.

Mate­rial living condi­tions also have an impact on patients’ deci­sions and on the treat­ment options avai­lable to them. “Some patients put off treat­ment because they can’t afford to take time off work ; others post­pone treat­ment to allow time to orga­nise care for depen­dents, made more dif­fi­cult by pre­ca­rious finan­cial resources. On the other hand, doc­tors some­times refrain from offe­ring major sur­ge­ry to cer­tain patients who are iso­la­ted or in very pre­ca­rious situa­tions, because they fear that retur­ning home will be too dif­fi­cult” adds Aurore Loretti.

Stu­dies also show that inequa­li­ties are more mar­ked among men than women throu­ghout the health care pro­cess, espe­cial­ly when they are iso­la­ted. “The fact of being a woman, or having women in one’s imme­diate circle, com­pen­sates in part for social sta­tus. Women are more fami­liar with the idea of care because they are often in charge of the family’s health and have bene­fi­ted from regu­lar check-ups in the event of pre­gnan­cy,” com­ments Aurore Loret­ti. Recent data7 shows, howe­ver, that while the (signi­fi­cant) inequa­li­ties in mor­ta­li­ty obser­ved among men are ten­ding to dimi­nish, they are increa­sing among women. “Here again, the pri­ma­ry cause is tobac­co consump­tion, which has risen shar­ply among women, par­ti­cu­lar­ly from disad­van­ta­ged back­grounds, since the 1970s,” adds Gwenn Menvielle.

After the disease, an impact on quality of life

Few stu­dies look at the post-treat­ment per­iod, but those that do show that social inequa­li­ties conti­nue to play an impor­tant role once treat­ment has been com­ple­ted. Lung can­cer, for example, is par­ti­cu­lar­ly impac­ted by social fac­tors, lea­ding to grea­ter social inequa­li­ties and grea­ter uncer­tain­ty when it comes to retur­ning to work8.

In a recent stu­dy9, Gwenn Men­vielle and her col­leagues loo­ked at the after­math of breast can­cer. The team fol­lo­wed near­ly 6,000 patients over a 2‑year per­iod and asses­sed their qua­li­ty of life using a score based on seve­ral cri­te­ria (fatigue, gene­ral and psy­cho­lo­gi­cal state, sexual health, side effects). At diag­no­sis, the dif­fe­rences in qua­li­ty of life bet­ween the two socio-eco­no­mic extremes, eva­lua­ted at 6.7, were alrea­dy signi­fi­cant. They increa­sed signi­fi­cant­ly over the course of the disease (score of 11) and remai­ned at a higher level than at diag­no­sis once treat­ment had been com­ple­ted (score of 10). 

For Gwenn Men­vielle, “the rea­sons for these dif­fe­rences are not to be found in the treat­ment, which was simi­lar for all the women. They pro­ba­bly come from the sup­port ele­ments around the medi­cal treat­ment : the fami­ly envi­ron­ment like­ly to pro­vide help on a dai­ly basis, and the mate­rial and finan­cial capa­ci­ty to fol­low care that extends beyond the pure­ly cura­tive, such as psy­cho­the­ra­py or phy­sio­the­ra­py ses­sions.” The resear­cher is now wor­king on a more detai­led ana­ly­sis of the impact of these factors.

Anne Orliac
1Cyrille Del­pierre, Sébas­tien Lamy, Pas­cale Gros­claude, Inéga­li­tés sociales face aux can­cers : du rôle du sys­tème de soins à l’incorporation bio­lo­gique de son envi­ron­ne­ment social ADSP n°94, mars 2016 https://​www​.hcsp​.fr/​e​x​p​l​o​r​e​.​c​g​i​/​A​d​s​p​?​c​l​e​f=151
2https://​www​.insee​.fr/​f​r​/​s​t​a​t​i​s​t​i​q​u​e​s​/​7​6​6​6​9​0​7​?​s​o​m​m​a​i​r​e​=​7​6​66953
3DARES Focus n°34, Les expo­si­tions des sala­riés aux pro­duits chi­miques can­cé­ro­gènes, juin 2023 citant l’enquête Sumer 2016–2017 https://​dares​.tra​vail​-emploi​.gouv​.fr/​p​u​b​l​i​c​a​t​i​o​n​/​l​e​s​-​e​x​p​o​s​i​t​i​o​n​s​-​d​e​s​-​s​a​l​a​r​i​e​s​-​a​u​x​-​p​r​o​d​u​i​t​s​-​c​h​i​m​i​q​u​e​s​-​c​a​n​c​e​r​o​genes
4OCDE, Pro­fils sur le can­cer par pays : France 2023, Édi­tions OCDE, Paris, https://​doi​.org/​1​0​.​1​7​8​7​/​1​d​d​7​d​d​7f-fr.
5OCDE, Pro­fils sur le can­cer par pays : France 2023, Édi­tions OCDE, Paris, https://​doi​.org/​1​0​.​1​7​8​7​/​1​d​d​7​d​d​7f-fr.
6id.
7https://​www​.inega​lites​.fr/​i​n​e​g​a​l​i​t​e​s​-​e​s​p​e​r​a​n​c​e​s​-​d​e​-​v​i​e​-​s​e​l​o​n​-​c​a​t​e​g​o​r​i​e​-​s​o​c​i​a​l​e​-​e​t​-sexe
8C. Chouaïd & al. Déter­mi­nants sociaux et can­cer du pou­mon Social deter­mi­nants and lung can­cer, https://​www​.scien​ce​di​rect​.com/​s​c​i​e​n​c​e​/​a​r​t​i​c​l​e​/​a​b​s​/​p​i​i​/​S​1​8​7​7​1​2​0​3​1​7​3​00654, Revue des mala­dies res­pi­ra­toires actua­li­tés, vol. 9 issue 2, sep­tembre 2017, p. 332–337
9José Luis San­do­val, Gwenn Men­vielle & al. Magni­tude and Tem­po­ral Varia­tions of Socioe­co­no­mic Inequa­li­ties in the Qua­li­ty of Life After Ear­ly Breast Can­cer : Results From the Mul­ti­cen­tric French CANTO Cohort, Jour­nal of Cli­ni­cal Onco­lo­gy vol. 42, n°24, juin 2024 https://​doi​.org/​1​0​.​1​2​0​0​/​J​C​O​.​2​3.020

Support accurate information rooted in the scientific method.

Donate